跳至主要内容
临床试验/NL-OMON54735
NL-OMON54735招募中2 期

FLUOPANC-trial - Intraoperative near-infrared fluorescence imaging in pancreatic- and extrahepatic bile duct tumors using cRGD-ZW800-1 and dedicated imaging systems: A phase II feasibility, dose-ranging and optimal dose-(interval) selection trial - FLUOPANC-trial

eids Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients >18 years old;
  • - Patients scheduled and eligible for open/robotic resection because of
  • (histologically proven) pancreatic carcinoma with or without neoadjuvant
  • treatment. As well as patients scheduled and eligible for resection because of
  • (histologically proven) distal or perihilar cholangiocarcinoma with or without
  • neoadjuvant treatment.
  • - All women of childbearing potential and all males must practice effective
  • contraception during the study and be willing and able to continue
  • contraception for at least 30 days after their last dose of study treatment.
  • - Patients should be capable and willing to give informed consent before study
  • specific procedures;

排除标准

  • - History of a clinically significant allergy or anaphylactic reactions;
  • - Patients with renal insufficiency (eGFR<60 ml/min/1,73 m2);
  • - Patients with a previous kidney transplantation in the medical history;
  • - Pregnant women, or women giving breast feeding;
  • - Patients who are immunocompromised and do not have the ability to respond
  • normally to an infection due to an impaired or weakened immune system, caused
  • by either a pre-existing disease or concomitant medications (excluding intended
  • neoadjuvant treatment);
  • - Presence of any psychological, familial, sociological or geographical
  • condition potentially hampering compliance with the study protocol and
  • follow-up schedule; those conditions should be discussed with the patient
  • before registration in the trial;
  • - Any condition that the investigator considers to be potentially jeopardizing
  • the patients well-being or the study objectives.

研究者

相似试验